![M. Scott Salka](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Scott Salka
Directeur Général chez
Vesper Biologics, Inc.
Profil
M.
Scott Salka is the founder of Ambit Biosciences Corp.
(founded in 2001) and Rakuten Medical, Inc. (founded in 2010).
He is also the founder of Sequana Therapeutics, Inc. Mr. Salka's current jobs include Chief Executive Officer positions at Vesper Biologics, Inc., CendR, Inc., and Arog Pharmaceuticals, Inc. where he holds the title of Co-Chief Executive Officer & Director.
He also holds Director positions at San Diego State University and BIOCOM, and a Director position at SDSU College of Business Administration.
Mr. Salka's former jobs include Chief Executive Officer & Director positions at AmpliPhi Biosciences Corp., Arcaris, Inc., and 454 Life Sciences Corp.
He also held the position of Independent Director at Sorrento Therapeutics, Inc. Additionally, he held Principal positions at Goodrich Corp., Unisys Corp., Roche Diagnostics GmbH, Boehringer Ingelheim Corp., and Parke, Davis & Co. LLC.
Mr. Salka received an MBA degree from Carnegie Mellon University and an undergraduate degree from San Diego State University.
Postes actifs de M. Scott Salka
| Sociétés | Poste | Début |
|---|---|---|
Vesper Biologics, Inc. | Directeur Général | - |
CendR, Inc. | Directeur Général | - |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/01/2009 |
SDSU College of Business Administration
 SDSU College of Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Arog Pharmaceuticals, Inc.
 Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Directeur Général | 01/03/2018 |
Anciens postes connus de M. Scott Salka
| Sociétés | Poste | Fin |
|---|---|---|
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Directeur Général | 12/04/2021 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Directeur Général | 31/05/2017 |
Rakuten Medical, Inc.
 Rakuten Medical, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops and commercializes precision & cell-targeting photoimmunotherapy | Directeur Général | 01/05/2015 |
| SORRENTO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/03/2014 |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de M. Scott Salka
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Goodrich Corp.
 Goodrich Corp. Aerospace & DefenseElectronic Technology Provides systems manufacturing and related services to the aerospace, defense and homeland security markets | Electronic Technology |
Unisys Corp.
 Unisys Corp. Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Sequana Therapeutics, Inc.
 Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops proprietary gene therapy products | Commercial Services |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Arcaris, Inc.
 Arcaris, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic, proteomic, and cell biological systems for direct identification and validation of novel drug targets | Commercial Services |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Commercial Services |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Health Services |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Parke, Davis & Co. LLC
 Parke, Davis & Co. LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Vesper Biologics, Inc. | |
CendR, Inc. | |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Health Technology |
SDSU College of Business Administration
SDSU College of Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rakuten Medical, Inc.
Rakuten Medical, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops and commercializes precision & cell-targeting photoimmunotherapy | Health Technology |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
